Camlin Fine Sciences peers

·ChemicalsChart ›

Companies like Camlin Fine Scienceslatest year

Camlin Fine SciencesCAMLINFINE · FY26 · this company
Market cap₹1,581
P/E56.38×
Sales growth+22.7%
ROE2.8%
Clean Science and TechnologyCLEAN · FY26
Open ›
Market cap₹7,867
P/E34.25×
Sales growth+10.5%
ROE15.3%
Deepak NitriteDEEPAKNTR · FY26
Open ›
Market cap₹20,138
P/E36.58×
Sales growth+61.8%
ROE9.8%
Bayer CropscienceBAYERCROP · FY26
Open ›
Market cap—
P/E—
Sales growth—
ROE23.7%

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

CAMLINFINE₹82.32

Camlin Fine Sciences Limited

· Chemicals
₹ CrorePeersCLEANDEEPAKNTRBAYERCROPTIRUMALCHMATULSHKPAUSHAKLTDANURASMcap ₹1,581 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
CAMLINFINE
FY26
CLEAN
FY26
DEEPAKNTR
FY26
BAYERCROP
FY26
Peer
Average
Valuation — at last close
P/E56.38×◆ 34.25×36.58×—35.42× +59%
P/B◆ 1.52×4.97×3.45×—4.21× -64%
EV/EBITDA◆ 19.24×21.10×21.65×—21.38× -10%
Market Cap₹1,581 Cr₹7,867 Cr₹20,138 Cr—₹14,002 Cr -89%
Growth
Revenue CAGR 3Y◆ 0.82%0.73%-0.36%—0.18% +343%
Revenue CAGR 5Y7.74%◆ 13.30%12.59%5.90%10.60% -27%
Net Income CAGR 3Y-16.06%◆ -8.03%-13.54%—-10.79% -49%
Revenue YoY (latest Q)22.74%10.53%◆ 61.75%—36.14% -37%
Net Income YoY (latest Q)-214.78%4.69%◆ 234.89%—119.79% -279%
Profitability
EBITDA Margin6.20%◆ 37.12%12.43%15.40%21.65% -71%
Net Income Margin1.37%◆ 24.01%6.98%12.14%14.38% -90%
Return on Common Equity2.84%15.31%9.81%◆ 23.70%16.27% -83%
Return on Capital Employed2.85%18.08%10.65%◆ 25.34%18.02% -84%
Return on Assets1.08%◆ 13.55%6.72%12.59%10.95% -90%
Credit & Quality
Total Debt/Equity0.67×◆ 0.00×0.26×—0.13× +415%
Interest Coverage0.49×◆ 783.81×16.43×39.38×279.87× -100%
Scale — latest FY
Revenue / Total Income₹1,723 Cr₹957 Cr₹7,887 Cr₹5,675 Cr₹4,840 Cr -64%
Net Income₹23.5 Cr₹230 Cr₹551 Cr₹689 Cr₹490 Cr -95%
Total Assets₹2,324 Cr₹1,783 Cr₹8,681 Cr₹5,699 Cr₹5,388 Cr -57%
EPS₹1.46₹21.61₹40.36—₹30.99 -95%
Book Value per Share₹54.19₹149.02₹427.92—₹288.47 -81%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.